You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. FDA approves gemcitabine intravesical system for non-muscle invasive bladder cancer
- 2. FDA clears J&J's drug-device combo for bladder cancer
- 3. Health Check: At risk of third ‘strike', Clinuvel argues its executive pay is ‘appropriate'
- 4. AI algorithm turns mammograms into a 'two-for-one' test for women's heart health
- 5. Global Breast Cancer Antibody Drug Conjugates Market Opportunity, Patent, Price, Approved Drug Sales & Clinical Trials Insight 2030
- 6. Health Check: Coronary plaque buster Artrya launches $80 million raising
- 7. Comprehensive analysis of MGLL as a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma
- 8. GADD45G as a novel prognostic biomarker and therapeutic target in glioma: integrative analysis of bulk and single-cell RNA sequencing
- 9. Silexion Therapeutics Reports Positive Preclinical Data Demonstrating SIL204's Reach and Activity in Major Pancreatic Cancer Metastatic Sites Following Systemic Administration
- 10. A comparative study of postural fixation techniques for radiotherapy in upper abdominal malignancies
Last updated at 1:19 GMT
Hot News Makers
Health/Pharma Companies
-
35340.07
-
21306.58
-
11974.29
-
11795.87
-
9839.52
-
6800.81
-
6287.00
-
6165.93
-
5945.70
-
5786.90
Drugs, Treatments, Trials
-
24962.57
-
10260.94
-
7711.21
-
6619.96
-
2088.25
-
1617.43
-
1525.96
-
1447.89
-
1291.99
-
1139.04
Last updated at 0:10 GMT
